Open Access
Performance standards for antimicrobial susceptibility testing
Reads0
Chats0
TLDR
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.Abstract:
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition. The standards contain information about both disk (M02) and dilution (M07 and M11) test procedures for aerobic and anaerobic bacteria. Clinicians depend heavily on information from the microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results demands that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and QC using the procedures standardized in the most current editions of M02, M07, and M11. Users should replace the tables published earlier with these new tables. (Changes in the tables since the previous edition appear in boldface type.) Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI supplement M100S (ISBN 1-56238-923-8 [Print]; ISBN 1-56238924-6 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2016. The data in the interpretive tables in this supplement are valid only if the methodologies in M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition are followed.read more
Citations
More filters
Journal ArticleDOI
Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase
Cesar A. Arias,Cesar A. Arias,Martha Vallejo,Jinnethe Reyes,Diana Panesso,Jaime A. Moreno,Elizabeth Castañeda,Maria V. Villegas,Barbara E. Murray,John P. Quinn +9 more
TL;DR: The cfr gene was unable to detect in any of the human staphylococci screened (either clinical or colonizing isolates) and the detection of cfr-mediated linezolid resistance might be compromised by the use of the disk diffusion or Etest method.
Journal ArticleDOI
Characterization of Staphylococcus aureus Isolates from Nasal Cultures Collected from Individuals in the United States in 2001 to 2004
Fred C. Tenover,Sigrid K. McAllister,Gregory E. Fosheim,Linda K. McDougal,Roberta B. Carey,Brandi Limbago,David Lonsway,Jean B. Patel,Matthew J. Kuehnert,Rachel J. Gorwitz +9 more
TL;DR: The proportions of MRSA isolates that were susceptible to chloramphenicol, clindamycin, and erythromycin were lower in 2003 and 2004 than in 2001 and 2002, although none of these differences was statistically significant.
Journal ArticleDOI
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
Hosam M. Zowawi,Brian M. Forde,Mubarak Alfaresi,Abdulqadir Alzarouni,Yasser Farahat,Teik Min Chong,Wai-Fong Yin,Kok-Gan Chan,Jian Li,Mark A. Schembri,Scott A. Beatson,David L. Paterson +11 more
TL;DR: The complete genome of a pandrug-resistant Klebsiella pneumoniae isolate is determined, representing the first complete genome sequence of CRE resistant to all commercially available antibiotics and revealing the critical role of mobile resistance elements in accelerating the emergence of resistance to other last resort antibiotics.
Journal ArticleDOI
Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in The Netherlands.
W J B Wannet,E. Spalburg,Max Heck,Gerlinde N. Pluister,E Tiemersma,Rob J. L. Willems,X. W. Huijsdens,A J de Neeling,Jerome Etienne +8 more
TL;DR: It was found that up to 15% of all MRSA isolates detected in The Netherlands harbored the PVL genes, a highly potent toxin which is involved in severe skin infections and necrotizing pneumonia, even in previously healthy individuals.
Journal ArticleDOI
Ampicillin-Resistant Non-β-Lactamase-Producing Haemophilus influenzae in Spain: Recent Emergence of Clonal Isolates with Increased Resistance to Cefotaxime and Cefixime
Silvia García-Cobos,José Campos,Edurne Lázaro,Federico Román,Emilia Cercenado,César García-Rey,María Pérez-Vázquez,Jesús Oteo,Francisco J. de Abajo +8 more
TL;DR: The sequence of the ftsI gene encoding the transpeptidase domain of penicillin-binding protein 3 (PBP 3) was determined for 354 nonconsecutive Haemophilus influenzae isolates from Spain this article.